Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection. - Wikidata - wikimedia - TriplyDB

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

http://www.wikidata.org/entity/Q35724734

about

Reflections upon human cancer immune responsiveness to T cell-based therapy Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Global transcriptional analysis for biomarker discovery and validation in cellular therapies.Immune regulation of cancer Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments.Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.Gene expression profiling of cutaneous wound healing.Potency analysis of cellular therapies: the emerging role of molecular assays A genetic inference on cancer immune responsiveness The immunologic aspects of poxvirus oncolytic therapy New take on comparative immunology: relevance to immunotherapy.Gene-expression profiling in vaccine therapy and immunotherapy for cancer Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.Cooperativity of adaptive and innate immunity: implications for cancer therapy.Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.Dendritic cell subsets as vectors and targets for improved cancer therapy Dendritic cells and immunity against cancer.Immunotherapy in nonmelanoma skin cancer.Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.Harnessing the immune system for the treatment of melanoma: current status and future prospects.Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.Management of superficial basal cell carcinoma: focus on imiquimod.Analysis of vaccine-induced T cells in humans with cancer.Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells.Turning laboratory findings into therapy: a marathon goal that has to be reached.

P2860

Q27004674-5CB2351D-B0A3-4FE7-A4D2-DC5CF0BD730C Q28389479-012045C3-EB73-4B61-8D6D-1A0450C4D61F Q30276126-54274BDD-4D56-4DD4-8B76-312B885EECFA Q30422102-0F9784BA-3C30-4E64-A5AC-D17C4A1AF96E Q30423599-B86A0C47-1298-49B3-AEBC-27DDEFA53A7A Q30438965-0CCF2605-1B03-4A21-9FCB-3F98B077D6A9 Q30440347-5A7F1C25-1531-41D6-9FEB-332F4CD148B7 Q33302568-EEA3896B-D995-48B8-A379-2FEAEAC0A2F7 Q33479314-F06BB901-8340-4501-BB2C-827C3D144BBC Q34171422-DB50679E-B45C-4B4E-B7AB-FB81938F53F0 Q34586327-F51BB2A8-3522-41AB-A4F7-BA4A74CF6B1D Q35047686-B1C65558-8E05-4289-AD08-3C980A40CB20 Q35193892-0A551CFC-3CC8-4368-A4B1-90D0BC19F7B9 Q35541507-6BECA85C-4904-46BD-8E5E-968A2598E457 Q35606746-C8CCBCFE-AE96-4F87-9FDF-359F5AD14F97 Q35649056-5F33F772-4FBC-445C-95E5-3F13196F2B4A Q35840586-BBC7B4D1-7B57-4E55-8A0A-A6F804C22046 Q36057497-CB87779C-5D6B-4531-8B7F-47D154F09708 Q36115128-E1523535-72DE-443B-920B-DFCF9049BC53 Q36126352-8ADCBFBF-AB26-4258-B17F-3A5ADC2755CD Q36138329-599524FF-20C8-4343-9806-B534CBABCDC0 Q36419244-A6D124AC-9930-4CD6-8B41-6A9A19B31406 Q36429508-B06FB63B-9CBB-481B-AB62-A669667FCEDB Q36476394-E6E4A4EA-ABA9-4977-AE2D-47D3A96BD768 Q36580172-6928D914-7588-4D9D-873D-276A365BC024 Q36632306-C6788A23-EA04-4A8E-A410-E167A84356F0 Q36782609-B3ED478D-827B-4B4E-97F1-AA442092D182 Q37394755-A6E50577-0A27-4F49-812D-29654393D74C Q37758502-1CC41539-C388-4676-A1C9-97C08B8DF03B Q37821074-08393793-69E2-4E98-9700-9FDC025FA2C8 Q38014084-86BE2B08-DF7C-4125-959F-5EF5DD9F686F Q38195656-FD58AFDB-592E-4E80-AE45-C0CEE4E7998E Q38806243-337A99FF-9D85-4008-BE72-5092EB0C0026 Q38875037-334EA699-8A08-4212-96E5-D8FA82CD9749 Q39705893-3B0A6FA4-BB5B-4F97-81C6-4810A76F5010 Q40014321-7DBC00B8-BB7D-4324-A480-8AACA7DBD175 Q41272202-733BD3C5-390D-4B8D-A3E4-4744FE52CA77 Q42645831-6C3CAFBC-75CE-4C0D-BDD5-FCF3E089E1DF Q54956643-459058B9-C63A-4435-A476-97C138172F73

P2860

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

http://www.wikidata.org/entity/Q35724734

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Sequential gene profiling of b ...... irements for tissue rejection.

@ast

Sequential gene profiling of b ...... irements for tissue rejection.

@en

type

label

Sequential gene profiling of b ...... irements for tissue rejection.

@ast

Sequential gene profiling of b ...... irements for tissue rejection.

@en

prefLabel

Sequential gene profiling of b ...... irements for tissue rejection.

@ast

Sequential gene profiling of b ...... irements for tissue rejection.

@en

P1433

Q35724734-1D11A7A7-8713-44D7-9E3B-B859354EB522

P1476

Q35724734-876503D7-BD42-41BD-B2E5-D001506756C1

P2093

Q35724734-0FF63A8E-E70B-42DE-891A-E4E84F86C376

Q35724734-1B051D05-005E-4469-9711-E6A57C71149D

Q35724734-209E9E4E-320F-476A-B91A-4AF9C9DA7BD1

Q35724734-21A67633-35BF-4603-ABB1-845024E44B94

Q35724734-34F602DA-02B4-41EB-93B3-C0DE7B35D6BD

Q35724734-40F0F3D1-57D0-418F-8851-4FA04C9D4B82

Q35724734-5DFCD770-8A8A-4C25-A421-EE79364E9EBB

Q35724734-62EDDE04-B090-45EF-9DFF-7ED67EBBCBB9

Q35724734-7CC16510-ABFC-4B2A-A697-453AB6D34EE2

Q35724734-85442596-8277-4071-B71D-7C803CAC7019

P2860

Q35724734-013ECA2A-B3FB-409D-9678-B491596DEE77

Q35724734-0241EF55-3C70-4553-9057-BE7F51FDEB8B

Q35724734-030EC532-0998-481E-B7E9-3A9C3FC7E7AF

Q35724734-0D7F1CDD-B20C-49CC-A6A9-BAFEAF2C1969

Q35724734-1197E88F-9378-4232-A7E2-5C0C28D62386

Q35724734-12F0261A-51A4-46BB-B65D-EE8A68E47CE2

Q35724734-1C671B2C-8F23-48F5-9188-A4F6F9B32174

Q35724734-1F6DF155-0502-42CA-A911-8F905A323F91

Q35724734-20F92563-F08E-41F7-BD57-8E038C14978F

Q35724734-307A8BDD-BA33-4C3F-A220-F36F9C297A3B

P2888

Q35724734-6F49D1F2-8897-4C1E-B6E8-BD92C3380BD0

P304

Q35724734-1C0405DF-C9EB-4096-B272-AC3D3FE95938

P31

Q35724734-66224858-7623-4152-8694-0740C2DEC816

P356

Q35724734-61CAE9EB-846C-4D42-AE7F-99B4E7F0DAB7

P433

Q35724734-2DDF4E4F-CDBE-480F-AD5A-781D9F124928

P478

Q35724734-1EF50CCA-3711-40EE-A3CF-66E04E845600

P577

Q35724734-65501D8A-6C4C-4FF7-9104-E0215DAD5E69

P5875

Q35724734-B20E5BE8-B5F8-49C2-A39D-0D1600C1EEB5

P6179

Q35724734-B09F3419-D556-4584-B1A1-4D7BD5E1D440

P698

Q35724734-2D5A4759-B10C-4118-BD04-3A92E5EE664E

P921

Q35724734-6B574434-EF51-44B8-AEA7-C6A90ECAC98B

P932

Q35724734-B62DE80C-DE37-4FBD-A2D0-AD90258FDEE5

P356

P1433

P1476

Sequential gene profiling of b ...... irements for tissue rejection.

@en

P2093

Andrea Abati

http://www.w3.org/2001/XMLSchema#string

Armando Filie

http://www.w3.org/2001/XMLSchema#string

Calvin Astry

http://www.w3.org/2001/XMLSchema#string

Christopher Norwood

http://www.w3.org/2001/XMLSchema#string

Eleonora Aricó

http://www.w3.org/2001/XMLSchema#string

Ena Wang

http://www.w3.org/2001/XMLSchema#string

Francesco M Marincola

http://www.w3.org/2001/XMLSchema#string

Herbert B Slade

http://www.w3.org/2001/XMLSchema#string

Kina Smith

http://www.w3.org/2001/XMLSchema#string

Mitchell E Stashower

http://www.w3.org/2001/XMLSchema#string

P2860

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism

Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells

Cluster analysis and display of genome-wide expression patterns

Melanoma-restricted genes

A balanced review of the status T cell-based therapy against cancer

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration

RNA amplification for successful gene profiling analysis.

Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Systematic variation in gene expression patterns in human cancer cell lines

P2888

P304

R8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/GB-2007-8-1-R8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6580201

http://www.w3.org/2001/XMLSchema#string

P6179

1021097010

http://www.w3.org/2001/XMLSchema#string

P698

17222352

http://www.w3.org/2001/XMLSchema#string

P921

P932

1839129

http://www.w3.org/2001/XMLSchema#string